Growth Metrics

Neogenomics (NEO) Goodwill (2016 - 2026)

Neogenomics filings provide 13 years of Goodwill readings, the most recent being $524.0 million for Q1 2026.

  • On a quarterly basis, Goodwill changed 0.24% to $524.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $524.0 million, a 0.24% change, with the full-year FY2025 number at $524.3 million, changed 0.3% from a year prior.
  • Goodwill hit $524.0 million in Q1 2026 for Neogenomics, roughly flat from $524.3 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $527.1 million in Q1 2022 to a low of $522.8 million in Q3 2022.
  • Median Goodwill over the past 5 years was $522.8 million (2022), compared with a mean of $523.6 million.
  • The widest YoY moves for Goodwill: up 149.7% in 2022, down 0.83% in 2022.
  • Neogenomics' Goodwill stood at $522.8 million in 2022, then changed by 0.0% to $522.8 million in 2023, then changed by 0.0% to $522.8 million in 2024, then grew by 0.3% to $524.3 million in 2025, then dropped by 0.07% to $524.0 million in 2026.
  • The last three reported values for Goodwill were $524.0 million (Q1 2026), $524.3 million (Q4 2025), and $524.3 million (Q3 2025) per Business Quant data.